Zealic Health, Coriqa Clinical Partner To Support 'Proactive' Clinical Trials

Monitoring finds the error, a query surfaces it, and an audit documents it. By then, a small execution slip may already have grown into rework, protocol deviations, and compliance risk, with data cuts, database locks, and regulatory submissions exposed to the delay. Two Research Triangle life sciences companies argue that clinical trials should shift from reactive oversight to proactive intervention and prevention. Zealic Health's Chuck Piccirillo and Coriqa Clinical's Wendy Tomlinson describe how AI, digital technology, and hands-on clinical operations experience are meant to work together, and why technology alone will not close the gap between a protocol and daily trial execution.

Read the full article to see how the partnership frames the problem.